Table of Content


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Rapid influenza diagnostic tests industry 360 degree synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 End-use trends
2.1.3 Regional Trends
Chapter 3 Rapid Influenza Diagnostic Tests Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing prevalence of influenza
3.3.1.2 Technological advancements
3.3.1.3 Rising demand for early diagnosis and control of influenza
3.3.1.4 Increasing popularity of rapid diagnostic tests
3.3.1.5 Diagnostic advantages in influenza testing
3.3.2 Industry pitfalls & challenges
3.3.2.1 Lack of skilled professionals
3.3.2.2 Stringent regulations
3.4 Growth potential analysis
3.4.1 By end-use
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2021
3.7.1 Company matrix analysis, 2021
3.8 PESTEL analysis
Chapter 4 Rapid Influenza Diagnostic Tests Market, By End-use
4.1 Key segment trends
4.2 Hospitals
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Diagnostics centers,
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.4 Research laboratories
4.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.5 Others
4.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Rapid Influenza Diagnostic Tests Market, By Region
5.1 Key regional trends
5.2 North America
5.2.1 Market size, by country, 2017 - 2030 (USD Million)
5.2.2 Market size, by end-use, 2017 - 2030 (USD Million)
5.2.3 U.S.
5.2.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.2.4 Canada
5.2.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.3 Europe
5.3.1 Market size, by country, 2017 - 2030 (USD Million)
5.3.2 Market size, by end-use, 2017 - 2030 (USD Million)
5.3.3 Germany
5.3.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.3.4 UK
5.3.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.3.5 France
5.3.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.3.6 Italy
5.3.6.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.3.7 Spain
5.3.7.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.4 Asia Pacific
5.4.1 Market size, by country, 2017 - 2030 (USD Million)
5.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
5.4.3 China
5.4.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.4.4 Japan
5.4.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.4.5 India
5.4.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.4.6 Australia
5.4.6.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.4.7 South Korea
5.4.7.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.5 Latin America
5.5.1 Market size, by country, 2017 - 2030 (USD Million)
5.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
5.5.3 Brazil
5.5.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.5.4 Mexico
5.5.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.5.5 Argentina
5.5.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.6 Middle East & Africa
5.6.1 Market size, by country, 2017 - 2030 (USD Million)
5.6.2 Market size, by end-use, 2017 - 2030 (USD Million)
5.6.3 South Africa
5.6.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.6.4 Saudi Arabia
5.6.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
5.6.5 UAE
5.6.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 6 Company Profiles
6.1 Competitive dashboard, 2021
6.2 F. Hoffmann-La Roche Ltd
6.2.1 Business overview
6.2.2 Financial data
6.2.3 Product landscape
6.2.4 Strategic outlook
6.2.5 SWOT analysis
6.3 Abbott
6.3.1 Business overview
6.3.2 Financial data
6.3.3 Product landscape
6.3.4 Strategic outlook
6.3.5 SWOT analysis
6.4 Becton, Dickinson and Company
6.4.1 Business overview
6.4.2 Financial data
6.4.3 Product landscape
6.4.4 Strategic outlook
6.4.5 SWOT analysis
6.5 Coris BioConcept
6.5.1 Business overview
6.5.2 Financial data
6.5.3 Product landscape
6.5.4 Strategic outlook
6.5.5 SWOT analysis
6.6 DiaSorin SpA
6.6.1 Business overview
6.6.2 Financial data
6.6.3 Product landscape
6.6.4 Strategic outlook
6.6.5 SWOT analysis
6.7 Meridian Bioscience Inc.
6.7.1 Business overview
6.7.2 Financial data
6.7.3 Product landscape
6.7.4 Strategic outlook
6.7.5 SWOT analysis
6.8 Quidel Corporation
6.8.1 Business overview
6.8.2 Financial data
6.8.3 Product landscape
6.8.4 Strategic outlook
6.8.5 SWOT analysis
6.9 Sekisui Diagnostics
6.9.1 Business overview
6.9.2 Financial data
6.9.3 Product landscape
6.9.4 Strategic outlook
6.9.5 SWOT analysis
6.10 Thermo Fischer Scientific Inc.
6.10.1 Business overview
6.10.2 Financial data
6.10.3 Product landscape
6.10.4 Strategic outlook
6.10.5 SWOT analysis
6.11 Hologic Inc.
6.11.1 Business overview
6.11.2 Financial data
6.11.3 Product landscape
6.11.4 Strategic outlook
6.11.5 SWOT analysis



List of Tables

Data Tables
TABLE 1. Global rapid influenza diagnostic tests market, 2017 - 2021 (USD Million)
TABLE 2. Global rapid influenza diagnostic tests market, 2022 - 2030 (USD Million)
TABLE 3. Global rapid influenza diagnostic tests market, by end-use, 2017 - 2021 (USD Million)
TABLE 4. Global rapid influenza diagnostic tests market, by end-use, 2022 - 2030 (USD Million)
TABLE 5. Global rapid influenza diagnostic tests market, by region, 2017 - 2021 (USD Million)
TABLE 6. Global rapid influenza diagnostic tests market, by region, 2022 - 2030 (USD Million)
TABLE 7. Industry impact forces
TABLE 8. Hospitals market size, by region, 2017 - 2021 (USD Million)
TABLE 9. Hospitals market size, by region, 2022 - 2030 (USD Million)
TABLE 10. Diagnostics centers market size, by region, 2017- 2021 (USD Million)
TABLE 11. Diagnostics centers market size, by region, 2022 - 2030 (USD Million)
TABLE 12. Research laboratories market size, by region, 2017 - 2021 (USD Million)
TABLE 13. Research laboratories market size, by region, 2022 - 2030 (USD Million)
TABLE 14. Others market size, by region, 2017 - 2021 (USD Million)
TABLE 15. Others market size, by region, 2022 - 2030 (USD Million)
TABLE 16. North America rapid influenza diagnostic tests market size, by country, 2017 - 2021 (USD Million)
TABLE 17. North America rapid influenza diagnostic tests market size, by country, 2022 - 2030 (USD Million)
TABLE 18. North America rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 19. North America rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 20. U.S. rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 21. U.S. rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 22. Canada rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 23. Canada rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 24. Europe rapid influenza diagnostic tests market size, by country, 2017 - 2021 (USD Million)
TABLE 25. Europe rapid influenza diagnostic tests market size, by country, 2022 - 2030 (USD Million)
TABLE 26. Europe rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 27. Europe rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 28. Germany rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 29. Germany rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 30. UK rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 31. UK rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 32. France rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 33. France rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 34. Italy rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 35. Italy rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 36. Spain rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 37. Spain rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 38. Asia Pacific rapid influenza diagnostic tests market size, by country, 2017 - 2021 (USD Million)
TABLE 39. Asia Pacific rapid influenza diagnostic tests market size, by country, 2022 - 2030 (USD Million)
TABLE 40. Asia Pacific rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 41. Asia Pacific rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 42. China rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 43. China rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 44. Japan rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 45. Japan rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 46. India rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 47. India rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 48. Australia rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 49. Australia rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 50. South Korea rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 51. South Korea rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 52. Latin America rapid influenza diagnostic tests market size, by country, 2017 - 2021 (USD Million)
TABLE 53. Latin America rapid influenza diagnostic tests market size, by country, 2022 - 2030 (USD Million)
TABLE 54. Latin America rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 55. Latin America rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 56. Brazil rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 57. Brazil rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 58. Mexico rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 59. Mexico rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 60. Argentina rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 61. Argentina rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 62. MEA rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 63. MEA rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 64. South Africa rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 65. South Africa rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 66. Saudi Arabia rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 67. Saudi Arabia rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)
TABLE 68. UAE rapid influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
TABLE 69. UAE rapid influenza diagnostic tests market size, by end-use, 2022 - 2030 (USD Million)

Charts & Figures
FIG. 1 Top-down approach (Supply side analysis)
FIG. 2 Data Validation
FIG. 3 Rapid influenza diagnostic tests market size, 2017 -2030 (USD Million)
FIG. 4 Industry segmentation
FIG. 5 Global rapid influenza diagnostic tests market, 2017-2030 (USD Million)
FIG. 6 Growth potential analysis, by end-use
FIG. 7 Porter’s analysis
FIG. 8 Company matrix analysis, 2021
FIG. 9 PESTEL analysis
FIG. 10 Key segment trends, by end-use
FIG. 11 Key regional trends
FIG. 12 Competitive dashboard, 2021